Yang Shao Min

Ewing /PNET、Ewing )、 、 、 / 、 、 、,;: 、 / 、 、,.

SCI. 1． +X:; 2．:4.1G; 3．:4.1R -. 4．:4.1G; 1． 、 、 、 、.《 》 2020. 2．2014,,,.(2017 1 ) 3．,.《 》, 2015 (2016 1 ) 4．,,,,.《 、 、 》 2012,2012, 5．2012 6．2010 7． (2009 ) 8．2009-2010 1． OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases. J Neuropathol Exp Neurol. 2020;79(9):959-965. 2．Intraosseous schwannoma of the mobile spine: a report of twenty cases. Eur Spine J. 2018; 27(12): 3092-3104. 3．USP6.,2018,18(2),151-155. 4． 8.,2016,23(3):161-168. 5. 5． 1.,2013(5). 6．Mediastinal fetal rhabdomyoma in nevoid basal cell carcinoma syndrome: a case report and review of the literature. Virchows Arch. 2011;459:235-238. 7．Lack of protein 4.1G causes altered expression and localization of cell adhesion molecule Nectin-like 4 in testis and can cause male infertility. Mol Cell Biol. 2011; 31(11): 2276-2286. 8．LyGDI is a Promising Biomarker for Ovarian Cancer. International Journal of Gynecological Cancer. 2010; 20(3):316-322. 9．Protein 4.1R links E-cadherin/β-catenin complex to the cytoskeleton through its direct interaction with β-catenin and modulates adherens junction integrity. Biochimica et Biophysica Acta, 2009 (1788):1458-1465. 10．P57 KIP2.,2009;38(9):580-584. 11．HTERT.,2002(22):470-474. 12． hTERT 、,,2002(31):50-54. 13．Monoclonal Antibodies against Human Telomerase Reverse Transcriptase (hTERT): Preparation, Characterization and Application. Hybridoma 2001;20(4):249-255. (1),.《 》,.2020 1. (2),.《 》,,2018 (3),.《 》 2,,2017. (4),.《 》 6,,2017. (5),.《 》, 2,,2015 1 1. (6) 、 、.《 》,,2016. (7) 、 、,.《 》,,2013. (8) 、 、,.《 》,,2006. (9),.《Rosai&Ackerman 》 10,,2014. (10) 、,.《 — 》 2,,2011. (11),《WHO 》,, 2005. (12),,. 《 》,.2009. (13),《2002 WHO 》,,2006,. (14),.《Rosai&Ackerman 》 9,,2006. (15),.《 》.,2007.